In the same way scientists from the Vanderbilt Clinical Neuroscience Scholars (CNS) Program have benefited from their experiences in the clinical setting, an initiative is underway for Psychiatry, Neurology and Neurosurgery residents to have an opportunity to do bench work in the basic science labs.

Autopsies have revealed that some individuals develop the cellular changes indicative of Alzheimer’s disease without ever showing clinical symptoms in their lifetime.

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.

Melissa Darnall could easily look around her family reunions and pick out who had Huntington’s disease (HD). The genetic disorder had affected four of her five aunts and uncles and her father, and the balance problems and shakiness typical of HD were readily apparent in those siblings.